Tag: Stock pick

  • Telstra vs Woodside: Which ASX dividend stock comes out on top?

    A young investor working on his ASX shares portfolio on his laptop.

    Telstra vs Woodside shares: which dividend stock looks better now?

    When you’re hunting for dependable dividend income from the ASX, Telstra Group Ltd (ASX: TLS) and Woodside Energy Group Ltd (ASX: WDS) are two names most investors have pondered at some point. Both companies are giants in their sectors, both pay franked dividends, and both rank among the most widely held blue chips around. But if you’re weighing Telstra vs Woodside shares this month, which stock delivers the better overall package of yield, value, and momentum?

    The case for Telstra

    Telstra is Australia’s largest telecommunications and information services company. It offers a wide range of products including mobile, fixed, broadband, data, and digital services for residential and business customers. In recent years, Telstra has undertaken a major restructure and now operates via several business units, such as ServeCo and InfraCo, aiming to sharpen focus and capital allocation. Its presence still stretches internationally, but the core remains a dominant force in Australia.

    On fundamentals, a few things stand out. Telstra’s market cap sits at $53.58 billion, making it one of the largest companies on the ASX. The dividend yield clocks in at 4.35%, with a high franking rate of just over 90%. Its current P/E ratio is 24.27, and Telstra has delivered a modest year-to-date return of 3.5%. According to its most recent public description, Telstra now oversees distinct subsidiaries, designed to streamline and modernise operations. Historically, Telstra has paid consistent franked dividends, appealing to income investors, though the absolute growth in those dividends has been modest.

    The case for Woodside Energy

    Woodside Energy operates as Australia’s largest independent oil and gas producer, with extensive offshore and onshore assets. The company recently boosted its international scale by merging with BHP’s petroleum business, making it a global energy player. Based in Perth, Woodside is a top-tier ASX heavyweight known for its focus on LNG, oil, and gas and for pursuing new energy opportunities.

    Looking at the numbers, Woodside’s market cap is a hefty $58.72 billion. The company is currently serving up a 5.11% fully franked dividend yield – handily higher than Telstra’s. Its P/E ratio is 13.94, significantly lower than Telstra’s, indicating that the market is pricing Woodside’s earnings more conservatively. The company has posted a very strong year-to-date return of 42.1%, reflecting robust momentum. Historically, Woodside’s dividends tend to fluctuate along with commodity prices, but its commitment to returns is evident in a big dividend per share of $1.63 this year.

    Valuation comparison

    Here’s how Telstra and Woodside stack up on key quantitative measures:

    Metric Telstra Woodside
    Market Cap $53.58 billion $58.72 billion
    P/E Ratio 24.27 13.94
    Dividend Yield 4.35% 5.11%
    Earnings Per Share (EPS) 0.199 1.605
    Dividend Per Share 0.21 1.63
    Franking 90.48% 100%

    Note: While Telstra’s P/E and EPS are mathematically consistent, investors should keep in mind that Woodside’s substantially higher EPS aligns with its much greater dividend per share and yield. Both companies offer franked dividends, but Woodside’s are fully franked (100%), versus Telstra’s ~90%. Telstra trades on a much higher earnings multiple than Woodside. For context, these companies sit in very different sectors—telecommunications and energy—so direct P/E comparisons should be taken with a pinch of salt.

    Recent share price momentum

    Comparing recent share price performance up to October 2026:

    • Telstra closed at $4.81 on 1 October 2026, down 0.41% from the previous session. Over the past month, its movement has been steady but lacked major gains. Its year-to-date return is 3.5%.
    • Woodside closed at $30.89 on 1 October 2026, after a 3.11% decline that session. Despite that daily slip, the year-to-date return stands at a very strong 42.1%.

    Both companies have seen some day-to-day volatility, but Woodside has clearly outpaced Telstra by a wide margin in year-to-date share price performance.

    Which is the better buy?

    If I had to choose between Telstra and Woodside this month for a dividend-focused portfolio, my pick would be Woodside Energy. The reasons? Woodside’s yield is higher at 5.11%, it’s fully franked, and the dividend per share is substantially larger. Its valuation also looks more attractive, with a P/E ratio well below Telstra’s, suggesting the market doesn’t have especially high near-term growth expectations priced in. Combine that with Woodside’s dazzling 42% year-to-date share price rise, and I think the market’s enthusiasm is justified by both operational progress (post-BHP merger) and solid cash returns.

    Telstra is hardly a poor choice for those wanting defensive, steady dividend flow, but the growth and value currently appear more exciting at Woodside, even after such a strong run. Of course, energy stocks carry their own risks—earnings and payout levels are more tied to commodity cycles than Telstra’s relatively predictable telco business. But based strictly on this snapshot of yield, franking, value, and momentum, I’d lean toward Woodside as the better dividend buy right now.

    The post Telstra vs Woodside: Which ASX dividend stock comes out on top? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Woodside Energy Group Ltd right now?

    Before you buy Woodside Energy Group Ltd shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Woodside Energy Group Ltd wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Buy, hold, sell: Megaport, Northern Star, Woolworths shares

    Two brokers analysing stocks.

    S&P/ASX 200 Index (ASX: XJO) shares are down 0.3% to 8,709.9 points on Monday.

    Let’s review some new ratings on three ASX 200 shares.

    Megaport Ltd (ASX: MP1)

    The Megaport share price is $22.64, up 1.3% today and up 49% over 12 months. 

    Shawn Hickman from Market Matters is bullish on this ASX 200 tech share. 

    Hickman said: 

    Megaport (ASX: MP1) has upgraded its FY27 revenue and EBITDA margin guidance after securing new strategic AI infrastructure contracts, while also benefiting from earlier-than-expected execution of previously announced agreements.

    The stronger outlook demonstrates both incremental revenue from the new contracts and improving operating leverage as the business scales.

    MP1 is increasingly evolving from a pure network-connectivity business into a broader digital and AI infrastructure platform.

    We like MP1 moving into 2027 with the stock looking attractive ~$21-22.

    Northern Star Resources Ltd (ASX: NST)

    The Northern Star Resources share price is $24.09, up 0.3% today and down 3% over 12 months. 

    Arthur Garipoli from Dolphin Partners Financial Services has a hold rating on this ASX 200 gold share. 

    Garipoli said (courtesy The Bull): 

    This Australian gold producer recently rejected an indicative proposal from Gold Fields Limited to acquire 100 per cent of NST at an implied equity value of $A38.7 billion. The proposal included $A7.25 in cash and 0.3125 new Gold Fields shares.

    The NST board rejected the proposal on the grounds it materially undervalues NST and is highly opportunistic.

    Also, Elliott Investment Management announced it had increased its stake in NST to 6.24 per cent on September 10.

    We suggest investors continue holding for further developments.

    Woolworths Group Ltd (ASX: WOW)

    The Woolworths share price is $38.28, down 0.2% today and up 45% over 12 months. 

    Steven Springford from Catapult Wealth has a sell rating on this ASX 200 consumer staples share. 

    Springford said: 

    The supermarket giant has managed a solid recovery. Group net profit before tax and significant items of $1.599 billion in full year 2026 was up 15.4 per cent on the prior corresponding period. Group sales of $71.5 billion were up 3.6 per cent.

    The balance sheet is in good shape and selling groceries is a defensive business. However, this is a recovery from a weaker base rather than a new growth phase.

    The shares have risen from $26.70 on September 30, 2025 to trade at $38.77 on September 30, 2026. The shares are trading at a premium, in our view.

    Investors can consider cashing in some gains before re-deploying the capital in cheaper growth orientated alternatives.

    The post Buy, hold, sell: Megaport, Northern Star, Woolworths shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Woolworths Group right now?

    Before you buy Woolworths Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Woolworths Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Buy, hold, sell: Myer, Develop Global, Netwealth shares

    A smiling woman sips coffee at a cafe ready to learn about ASX investing concepts.

    S&P/ASX 200 Index (ASX: XJO) shares are 0.4% higher at 8,719.7 points on Monday.

    Let’s start the new week with some fresh ratings from the experts (courtesy The Bull). 

    Netwealth Group Ltd (ASX: NWL)

    The Netwealth share price is $17.04, down 1% today and down 44% over 12 months. 

    Steven Springford from Catapult Wealth has a buy rating on this ASX financial share. 

    Springford said: 

    This financial services company operates an investment management platform used by financial advisors in Australia.

    The company delivered record total income of $391.1 million in full year 2026, an increase of 20.6 per cent on the prior corresponding period. Platform revenue increased 21 per cent. Record adjusted net profit after tax of $135.4 million was up 16.2 per cent.

    The company is expecting even stronger inflows in fiscal year 2027.

    Netwealth is well positioned to capture increasing market share. The weaker share price is appealing at these levels.

    Develop Global Ltd (ASX: DVP)

    The Develop Global share price is $4.40, up 1% today and up 1% over 12 months. 

    Arthur Garipoli from Dolphin Partners Financial Services has a hold rating on this copper and zinc miner.

    He said: 

    DVP projects include Woodlawn, Yitirrti and the Pioneer Dome. Fiscal year 2027 will include a full year of production from the Woodlawn copper-zinc mine in New South Wales and the start of lithium direct shipping ore sales at the Pioneer Dome lithium mine in Western Australia.

    The Woodlawn operation is expected to mine between 21,000 and 23,500 tonnes of contained copper equivalent metal in full year 2027, providing a strong cash flow base.

    Cash flow will also be supported by first production and sales at the Pioneer Dome in the December quarter. DVP has a history of moving development projects into production amid the company embarking on its next growth stage.

    Myer Holdings Ltd (ASX: MYR)

    The Myer share price is steady at 19 cents on Monday, and down 62% over 12 months. 

    Garipoli has a sell rating on this ASX consumer discretionary share. 

    Garipoli explained: 

    This department store retailer recently posted a statutory loss after tax of $276.5 million in full year 2026, down 35.3 per cent on an actual basis. A one-off, non-cash, post tax impairment was $279.6 million.

    Underlying net profit after tax of $42.5 million was 2.9 per cent lower on an actual basis. Comparable sales grew 0.7 per cent.

    No final dividend was declared.

    Myer is now relying on the upcoming Christmas period to bolster sales. But challenges persist given a higher interest rate environment and soaring cost of living expenses.

    The post Buy, hold, sell: Myer, Develop Global, Netwealth shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Netwealth Group right now?

    Before you buy Netwealth Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Netwealth Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool Australia has recommended Myer. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • ANZ vs AMP: Which ASX blue chip is the better buy this month?

    Woman and man at work looking at data on a tablet at work.

    ANZ Group vs AMP shares: Which blue chip is the better buy this month?

    When it comes to big names on the ASX, few stand out as much as ANZ Group Holdings Ltd (ASX: ANZ) and AMP Ltd (ASX: AMP). Both are pillars of the Australian financial sector, but they play very different games—ANZ as one of the nation’s “big four” banks, and AMP as a diversified wealth manager with a long history. With changing markets, improved performance, and new strategies underway, plenty of investors are weighing up ANZ Group vs AMP shares right now. So, which blue chip shapes up as the better buy this month?

    The case for ANZ

    ANZ is one of Australia’s giant banks—part of the “big four,” with a strong foothold in retail, business, and institutional banking across nearly 30 markets worldwide. While its roots stretch back decades, ANZ is anything but stale; it’s continued evolving, adapting its product offering for millions of customers across Australia, New Zealand, Asia-Pacific, and beyond.

    What stands out for ANZ right now is its solid dividend yield of 4.33%, which, along with a sizeable market cap of $112.16 billion, underscores its status as a blue-chip mainstay. According to its company profile, ANZ caters to a customer base of more than 8.5 million people globally, though keep in mind this number may have shifted since. ANZ’s franking on its dividends currently sits at 75%, which is a welcome boost for many Aussie investors. The bank’s P/E ratio of 19.42 looks reasonable when viewed against its strong position in the market. Year to date, shares are up 7.7%, suggesting a steady performance in 2026 so far.

    The case for AMP

    AMP has been around since 1849, forging a reputation in superannuation, investment management, life insurance, and a select set of banking services. While the company has faced its share of public challenges, recent years have seen AMP redefine itself, offloading its institutional funds management business and steering its financial advice arm into a fresh joint venture. AMP’s story is about rebuilding and repositioning for a new era.

    From a numbers perspective, AMP offers a market cap of $6.27 billion—much smaller than ANZ’s but still sizeable by most standards. Its P/E ratio is 34.86, reflecting the market’s expectation of future growth (or possibly a premium for turnaround potential). The current dividend yield is 1.94% with 20% franking, noticeably lower than ANZ’s yield and franking. However, the real eye-catcher is AMP’s year-to-date return: a whopping 44.5% as of 30 September 2026, showing very strong share price momentum this year.

    Valuation comparison

    When it comes to straight-up fundamentals, there are some sizeable differences:

    Metric ANZ AMP
    Market Cap $112.16 billion $6.27 billion
    P/E Ratio 19.42 34.86
    Dividend Yield 4.33% 1.94%
    Dividend per Share $1.66 $0.05
    Franking 75% 20%
    Earnings per Share (EPS) 1.973 0.074

    ANZ trades on a lower P/E ratio than AMP, meaning investors are paying less for each dollar of earnings. It also offers more than double the dividend yield, with higher franking on those payouts. AMP’s valuation may reflect turnaround hopes or perceived growth from its new structure, but right now it’s considerably more expensive on a P/E basis.

    Note: AMP’s reported P/E ratio may be based on a different earnings measure (e.g. underlying or forward earnings) than the EPS figure shown, which is why these numbers may appear inconsistent.

    Recent share price momentum

    Comparing recent share price performance up to 30 September 2026:

    • ANZ closed at $38.31 on 30 September 2026, delivering a year-to-date return of 7.7%. In the last week of available data, it’s seen mild ups and downs, but trends sideways overall after some earlier strength in the month.
    • AMP closed at $2.60 on 30 September 2026, riding an impressive year-to-date performance of 44.5%. Its past week shows more short-term gains and positive sentiment from investors.

    Which is the better buy?

    Both ANZ and AMP bring something distinct to the table—ANZ the stable, high-yield blue-chip; AMP the smaller, turnaround financial with momentum on its side. Right now, though, I think the case is stronger for ANZ.

    The reasons? ANZ offers a much higher, better-franked dividend, trades at a far more accessible P/E ratio considering the size and strength of its franchise, and provides a level of predictability that AMP, still working through strategic change and capital structure tweaks, cannot quite match. AMP’s near-45% run-up this year is dazzling, but that sort of momentum can cool quickly if the turnaround doesn’t deliver. For investors chasing reliable yield and a dominant market position, my pick would be ANZ this month.

    The post ANZ vs AMP: Which ASX blue chip is the better buy this month? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Anz Group right now?

    Before you buy Anz Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Anz Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • If I buy $6,000 of Coles shares, how much dividend income will I receive?

    Man holding out Australian dollar notes, symbolising dividends.

    Owning Coles Group Ltd (ASX: COL) shares could be a wonderful pick for dividend income in the years ahead because of their stability and growth.

    Coles is best known for its supermarket business, the second-largest operator in Australia. It also has a liquor division which includes Coles Liquor and Liquorland, a 50% stake in Flybuys, and it offers financial products like insurance, credit cards and personal loans.

    Given that food is a life essential, I think Coles is one of the leading ASX defensive shares in Australia. Australia’s steady population growth is a key driver of demand for Coles’ products.

    I think Coles is one of the leading ASX blue-chip shares because of its track record of growing its payout and delivering a solid dividend yield.

    Let’s take a look what could happen with a $6,000 investment in Coles shares.

    Strength of the dividend

    Coles spun off from Wesfarmers Ltd (ASX: WES) more than seven years ago. Since then, the supermarket business has increased its annual dividend every year. None of Australia’s largest businesses can say that they have done the same – COVID-19 impacts, lower commodity prices, or inflation led to dividend cuts this decade for many of the large ASX shares.

    Coles has kept things consistent, and shareholders’ bank accounts have benefited.

    The ASX blue-chip share generated underlying net profit after tax (NPAT) growth of 13.7% to $1.25 billion in FY26, helping fund a 13% increase in the annual dividend per share to 78 cents per share.

    At the time of writing, the FY26 payout translates into a grossed-up dividend yield of 4.8%, including franking credits. But, that’s the past. Any investors buying Coles shares will receive the 2027 financial year dividend next, so we should focus on that.

    Excitingly, the payout is forecast to increase again in FY27. According to CommSec’s projection, the ASX blue-chip share is expected to pay an annual dividend of 83.5 cents per share. That would be year-over-year growth of 7%, much stronger than inflation.

    That projected payout for FY27 would also represent a forward grossed-up dividend yield of 5.2%, including franking credits.

    $6,000 investment in Coles shares

    If someone were to buy $6,000 of Coles shares today, they’d be able to buy 260 Coles shares.

    That could mean dividend cash of $217.10 from FY27 and grossed-up dividend income of $310.14 including franking credits.

    If I were looking for dividend income from an ASX blue-chip share, Coles would be a strong contender. But it’s not the only business I’d look at today for returns.

    The post If I buy $6,000 of Coles shares, how much dividend income will I receive? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Coles Group right now?

    Before you buy Coles Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Coles Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Capricorn Metals delivers solid Q1 gold output and expansion milestone

    The Capricorn Metals Ltd (ASX: CMM) share price is in focus after the company reported gold production of 31,218 ounces for the September 2026 quarter, in line with guidance, and announced the completion of the Karlawinda Expansion Project on schedule.

    What did Capricorn Metals report?

    • Gold production for Q1 FY27: 31,218 ounces (vs 30,437 ounces in Q4 FY26)
    • Karlawinda Expansion Project completed on time and within budget
    • Cash and gold on hand at 30 September 2026: $535.0 million (up from $507.0 million at 30 June)
    • Underlying cash build for the quarter: $62.2 million, prior to $42.7 million capital expenditure
    • FY27 production guidance of 137,000–147,000 ounces at AISC of $1,900–$2,100 per ounce reaffirmed

    What else do investors need to know?

    Mining activities continued at the expanded rate across the Karlawinda Gold Project, allowing for both strong gold output and the seamless integration of the new processing facilities. The commissioning of the expanded plant has increased processing capacity to 6.5 million tonnes per annum, with expected annual gold production now at 150,000 ounces going forward.

    Development is also progressing at Capricorn’s Mt Gibson Gold Project. During the quarter, $2.1 million was spent mainly on procurement and contract set-up, positioning the company well for a quick construction start after regulatory permits are received. Federal approvals have been secured and key state environmental assessments are underway.

    What’s next for Capricorn Metals?

    Capricorn expects to maintain steady production in line with its guidance for FY27, as the benefits of the Karlawinda Expansion Project begin to flow through. The company aims to lift output to 150,000 ounces per year at the Karlawinda operations, while advancing the Mt Gibson Gold Project, pending further permitting decisions.

    Investors will be watching for the release of more detailed operational and cost figures in Capricorn’s full quarterly report later in October, as well as regulatory progress and timelines at Mt Gibson.

    Capricorn Metals share price snapshot

    Over the past 12 months, Capricorn Metals shares have risen 5%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has fallen 3% over the same period.

    View Original Announcement

    The post Capricorn Metals delivers solid Q1 gold output and expansion milestone appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Capricorn Metals right now?

    Before you buy Capricorn Metals shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Capricorn Metals wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • ResMed vs Fisher & Paykel Healthcare: Which is better value?

    A female scientist in a laboratory setting using a tablet to review data, with a male scientist working in the background.

    ResMed vs Fisher & Paykel Healthcare shares

    Looking at the ASX 200 healthcare sector, you’re likely to come across two standout names: ResMed Inc (ASX: RMD) and Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH). Both are leaders in designing and manufacturing respiratory and sleep apnea devices. With the health tech industry under the spotlight, many investors want to know—between ResMed shares and Fisher & Paykel Healthcare shares, which offers better value right now?

    The case for ResMed

    ResMed is a global leader in sleep technology and respiratory devices, best known for its CPAP machines, masks, and related cloud-based software. Originally founded in Australia but now headquartered in the US, ResMed operates across more than 140 countries and serves both hospitals and home-based patients. Its broad product range targets sleep apnea, COPD, and other respiratory conditions, as well as providing digital tools for healthcare professionals and carers.

    Notably, ResMed boasts a substantial market capitalisation at $45.51 billion, making it one of the larger players in the healthcare space. Its price-to-earnings (P/E) ratio sits at 21.51, and earnings per share are reported at 1.043. The current dividend yield is 1.11%, with a dividend per share of $0.38. However, it’s worth noting that its dividends are unfranked and—according to the data here—Year To Date Return is a negative -10.3%. This recent underperformance might catch the eye of value-focused investors looking for a turnaround.

    ResMed’s dividend record is steady with consistent, albeit modest, growth over the years, but it doesn’t offer franking credits—so it’s less appealing to income investors seeking tax-effective Australian dividends.

    The case for Fisher & Paykel

    Fisher & Paykel Healthcare is another respiratory heavyweight, based in New Zealand. While also strong in sleep apnea devices, Fisher & Paykel Healthcare puts even more emphasis on hospital-focused respiratory systems, particularly in acute and critical care. The company earns a large proportion of its revenue from the US and Europe, and invests heavily in research and development, maintaining a robust innovation pipeline.

    Fisher & Paykel Healthcare’s market cap sits at $21.97 billion—roughly half of ResMed’s. Its current P/E ratio is a hefty 57.56 and EPS is listed as 0.793. Dividend yield is just above ResMed at 1.18%, with dividend per share at $0.44, though these also come unfranked. What really jumps out to me, though, is the company’s strong price momentum: its Year To Date Return is 13.54%, a significant positive in contrast to ResMed’s negative performance.

    Their dividend stream includes both interim and supplemental payments, and like ResMed, there’s no franking benefit for Australian investors.

    Valuation comparison

    With both companies serving similar end-markets, their valuation metrics reveal a strong contrast:

    Metric ResMed Fisher & Paykel
    Market Cap $45.51 billion $21.97 billion
    P/E Ratio 21.51 57.56
    Dividend Yield 1.11% 1.18%
    Dividend per Share $0.38 $0.44
    Earnings per Share 1.043 0.793
    YTD Return -10.3% 13.5%

    ResMed trades at a notably lower P/E than Fisher & Paykel Healthcare, making it look comparatively cheaper based on earnings. The two offer similar dividend yields, both unfranked. ResMed also delivers a higher EPS.

    Recent share price momentum

    Comparing recent share price performance up to 30 September 2026:

    • As of 30 September 2026, ResMed shares closed at $31.98, rising 0.95% that day, but are down -10.3% for the year to date.
    • On the same date, Fisher & Paykel Healthcare shares closed at $37.43, rising 1.71% on the day, and are up 13.5% year to date.
    • Fisher & Paykel Healthcare has enjoyed stronger recent momentum, with a solid upward trend during September compared to ResMed’s more muted, slightly negative swings.

    Which is the better buy?

    If I’m weighing up ResMed and Fisher & Paykel Healthcare on value right now, I’d lean towards ResMed. Its P/E ratio of 21.51 is much lower than Fisher & Paykel Healthcare’s 57.56, suggesting ResMed shares are more attractively priced relative to current earnings—especially since both companies are exposed to similar markets and risks.

    While Fisher & Paykel Healthcare is running hot with a strong year-to-date share price gain, that momentum comes at the cost of a very steep valuation multiple. Even with a slightly higher dividend yield, I don’t see enough income upside to justify paying nearly three times the P/E for Fisher & Paykel Healthcare.

    Both companies are outstanding in healthcare tech, and Fisher & Paykel’s recent gains are impressive, but for pure valuation appeal, my pick would be ResMed. I think it’s offering better value for investors looking for quality, scale, and the potential for a turnaround in sentiment.

    The post ResMed vs Fisher & Paykel Healthcare: Which is better value? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in ResMed right now?

    Before you buy ResMed shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and ResMed wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Ingenia Communities Group updates on revised Warburg Pincus offer

    A smiling young couple sit with a finance professional at a computer, looking at the screen.

    The Ingenia Communities Group (ASX: INA) share price is in focus after the company updated investors on a revised acquisition proposal, highlighting continued interest from Warburg Pincus and ongoing progress with Peet Limited.

    What did Ingenia Communities Group report?

    • Received a further revised non-binding indicative proposal from Warburg Pincus to acquire 100% of Ingenia at $5.25 cash per stapled security.
    • The proposal is subject to due diligence and confidentiality arrangements.
    • Ingenia is still advancing its acquisition transaction with Peet Limited under the existing scheme implementation deed (SID).
    • No determination has been made that the Warburg Pincus proposal is superior or will be recommended to securityholders at this stage.

    What else do investors need to know?

    Ingenia has granted Warburg Pincus initial due diligence access on a non-exclusive basis, aiming to let Warburg Pincus firm up its offer. Importantly, the Ingenia Board emphasised that there is no certainty the proposal will become a formal binding offer or result in a transaction.

    Meanwhile, Ingenia continues with the acquisition by Peet under the terms agreed in August. The Board has put robust governance in place to assess all proposals with a focus on the best interests of Ingenia securityholders. At this stage, investors are advised that no action is needed.

    What’s next for Ingenia Communities Group?

    Looking ahead, Ingenia will work through its due diligence process with Warburg Pincus and continue progressing the Peet scheme in line with agreed timelines. The Board will assess any revised proposals to ensure decisions serve the interests of all securityholders.

    The outcome depends on whether Warburg Pincus’ proposal becomes sufficiently compelling and certain, and on any future recommendations by the Board under the SID with Peet. Investors should stay tuned for further updates.

    Ingenia Communities Group share price snapshot

    Over the past 12 months, Ingenia shares have declined 14%, trailing the S&P/ASX 200 Index (ASX: XJO), which has fallen 3% over the same period.

    View Original Announcement

    The post Ingenia Communities Group updates on revised Warburg Pincus offer appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Ingenia Communities Group right now?

    Before you buy Ingenia Communities Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Ingenia Communities Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • CSL unveils exclusive Alentis deal to advance rare disease treatments

    Happy doctor using her laptop.

    The CSL Ltd (ASX: CSL) share price is in focus after the company announced an exclusive agreement to co-develop and co-promote lixudebart for rare kidney and liver diseases, with an initial US$355 million payment to Alentis Therapeutics and plans for expanded trials.

    What did CSL report?

    • Entered exclusive deal with Alentis Therapeutics for lixudebart, a treatment targeting rare kidney and liver conditions
    • CSL to make an upfront payment of US$355 million to Alentis
    • Additional commercial milestone payments of up to US$1.2 billion possible
    • CSL will fund all upcoming Phase 2 and 3 trials for lixudebart in key indications
    • Profits from global sales to be shared, with 55% to CSL and 45% to Alentis

    What else do investors need to know?

    CSL’s new agreement centres around lixudebart, a novel antibody designed to slow both inflammation and fibrosis—key factors in organ damage for conditions like ANCA-associated vasculitis and rapidly progressive glomerulonephritis (AAV-RPGN). Both are life-threatening and currently have limited treatment options.

    The company plans to expand clinical trials to cover other rare diseases such as focal segmental glomerulosclerosis (FSGS) and primary sclerosing cholangitis (PSC), supporting the growth of CSL’s nephrology portfolio.

    What did CSL management say?

    Executive Vice President and Head of R&D Dr Bill Mezzanotte said:

    We believe lixudebart has the potential to become an important new therapeutic option to help improve kidney function and prevent progression to end-stage kidney disease…Our collaboration with Alentis reflects CSL’s commitment to building a leading global nephrology franchise, and our strategic intent to create high-value external partnerships.

    What’s next for CSL?

    Looking forward, CSL aims to complete the ongoing Phase 2 clinical trial for lixudebart and start new trials in additional rare kidney and liver diseases. The company’s strategy is to strengthen its position in nephrology through innovation and global partnerships.

    Investors can expect further updates as results from these trials are released and as CSL moves closer to potential commercialisation, which would generate shared global profits.

    CSL share price snapshot

    Over the past 12 months, CSL shares have declined 15%, trailing the S&P/ASX 200 Index (ASX: XJO), which has declined 3% over the same period.

    View Original Announcement

    The post CSL unveils exclusive Alentis deal to advance rare disease treatments appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • 1 ASX dividend stock down 19% I’d buy right now

    Piles of increasing coins on Australian $100 notes.

    The ASX dividend stock Universe Store Holdings Ltd (ASX: UNI) has fallen 19% from its 2026 high in February 2026, as the chart below shows. I think it’s a great time to invest in the ASX retail share.

    Universal Store says it owns a portfolio of premium youth fashion brands. Its principal businesses are Universal Store (trading as Universal Store and Perfect Stranger) and CTC (trading as the THRILLS and Worship brands),

    At the last count, it had 123 physical stores across Australia. Its strategy is to grow and develop its premium fashion apparel brands and retail formats, targeting fashion-focused customers.

    Higher dividend yield

    When a share price changes, it means investors can get a higher dividend yield.

    For example, if a business has a dividend yield of 6% and then the share price drops 10%, then the dividend yield becomes 6.6%, which is a big difference for investors wanting dividend income.

    As I’ve mentioned, Universal Store’s share price has fallen 19%, significantly boosting the dividend yield.

    In FY26, the ASX dividend stock hiked its annual dividend per share by 11.7% to 43 cents per share. That’s currently a grossed-up dividend yield of 8.1%, including franking credits, at the time of writing.

    The projection on Commsec suggests the business could hike its annual dividend per share by 4.7% to 45 cents per share. That implies a forward grossed-up dividend yield of 8.4%, including franking credits, at the time of writing.

    In terms of passive income, the company is clearly expected to deliver huge payouts.

    Ongoing growth

    The ASX dividend stock is showing it can deliver growth, even in weak economic conditions. Not many ASX retailers can say that right now.

    In FY26, the company generated group sales growth of 12.9% to $376.1 million, with particularly impressive performance by Perfect Stranger which grew sales by 40.8% to $35.9 million.

    It also reported that the gross profit margin improved by 140 basis points to 62.5%, and underlying net profit after tax (NPAT) rose by 16.3% to $40.5 million. As you can see, its profit margins rose despite inflation in costs.

    FY27 has started strongly and I think this bodes very well for future growth.

    In the first seven weeks of FY27, group direct-to-customer sales were up 9.1%, including Perfect Stranger sales growth of 45.8% (partly powered by like-for-like sales growth of 17.6%). Universal Store sales growth was 5.5%, with LFL sales growth of 2.9%.

    Management intends to open between 16 and 20 stores in FY27, including nine to ten new Universal Store locations, six to eight new Perfect Stranger stores and one or two new THRILLS stores.

    According to the projection on Commsec, the Universal Store share price is valued at 13x FY27’s estimated earnings. I think this is a great time to invest in the ASX dividend stock, though it’s not the only opportunity out there right now.

    The post 1 ASX dividend stock down 19% I’d buy right now appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Universal Store right now?

    Before you buy Universal Store shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Universal Store wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Universal Store. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.